ReviewFrontiers in immunology2026
Immunoglobulin G in aging and cancer.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunoglobulins are key effector molecules in humoral immunity and play fundamental roles in human health and disease through their complex structure-function relationships. Dysregulation of immunoglobulin production or function underlies numerous conditions, including inflammatory disorders, autoimmune diseases, and metabolic diseases. In the context of cancer, immunoglobulin G (IgG) is frequently enriched within tumor tissue and displays aberrant glycosylation, where it correlates with cancer progression, and its functional impact within the tumor microenvironment is drawing growing interest. Furthermore, recent studies have collectively identified as a novel aging-associated factor involved in multi-organ aging processes. Understanding the role and the mechanisms of immunoglobulins in both physiological and pathological conditions remain a major priority for researchers. Elucidating the underlying pathophysiology and mechanisms of IgG may therefore provide valuable insights for the development of new therapeutic strategies. In this review, we summarize recent progress in the study of IgG in aging and cancer and discuss its potential roles in the future landscape of immunology and biomedical research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.